Australia TGA ARTG record

Insulin syringe, fixed-needle

Australia TGA ARTG Registered Device · Avaderm Pty Ltd · Feel Tech Bio Co Ltd · Class IIa · Started March 13, 2024

Good Name: Avaderm Pty Ltd - Insulin syringe, fixed-needle

Device classification

Risk Class: Class IIa
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: March 13, 2024
Effective Date: March 13, 2024

Sponsor

Name: Avaderm Pty Ltd

Manufacturer

Name: Feel Tech Bio Co Ltd
Country: South Korea
Address: 1079-20 Charyeonggogae-ro Gwangdoek-myeon Cheonan-si, Dongnam-gu, Chungcheongnam-do, 31223

Intended purpose

This device is intended for subcutaneous injection of insulin. This device is single-use.

About this record

Access comprehensive regulatory information for Insulin syringe, fixed-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Avaderm Pty Ltd, manufactured by Feel Tech Bio Co Ltd in South Korea. The device registration started on March 13, 2024.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.